Acta Scientific Women's Health (ASWH)(ISSN: 2582-3205)

Letter to Editor Volume 2 Issue 7

Novel Coronavirus Disease (COVID-19): Pregnancy Issues

Goce Kalcev1*, Ivan Barbov2, Jovan Bozinovski2 and Elizabeta Zisovska3

1International PhD in Innovation Sciences and Technologies, University of Cagliari, Italy
2University Clinic for Neurology, Skopje, Republic of North Macedonia
3University Clinic for Gynecology and Obstetrics, Skopje, Republic of North Macedonia

*Corresponding Author: Goce Kalcev, International PhD in Innovation Sciences and Technologies, University of Cagliari, Italy.

Received: May 28, 2020; Published: June 26, 2020


Immune and physiological changes that occur during a woman's pregnancy place her in a high-risk group for the physical and mental health consequences of various factors [1]. Previous studies showed high rates of maternal mortality, abortion, and preterm labor after pneumonia caused by the H1N1, MERS, influenza A, and SARS viruses [2]. However, information on the impact of COVID-19 infection on mothers and newborns outcomes is very limited. COVID-19 is becoming a global health concern.



  1. Liu H., et al. “Why are pregnant women susceptible to viral infection: an immunological viewpoint?” Journal of Reproductive Immunology 139 (2020): 103-122.
  2. Alserehi H., et al. “Impact of Middle East Respiratory Syndrome coronavirus (MERS‐CoV) on pregnancy and perinatal outcome”. BMC Infectious Diseases 16 (2016): 105.
  3. Rasmussen SA., et al. “Coronavirus Disease 2019 (COVID-19) and Pregnancy: What obstetricians need to know”. American Journal of Obstetrics and Gynecology (2020).
  4. Lancet T. “Preliminary evidence suggests that new coronavirus cannot be passed from mother to child late in pregnancy”. The Lancet (2020).
  5. Li Q., et al. “Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia”. The New England Journal of Medicine (2020).
  6. Chen H., et al. “Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records”. The Lancet (2020).
  7. Wang X., et al. “A case of 2019 Novel Coronavirus in a pregnant woman with preterm delivery” (2020).
  8. Schwatz DA and Grahan AL. “Potential Maternal and Infant Outcomes from Coronavirus 2019-nCoV (SARS-CoV-2) Infecting Pregnant Women: Lessons from SARS, MERS, and Other Human Coronavirus Infections”. Viruses2 (2020): 194.
  9. Yang H., et al. “Novel coronavirus infection and pregnancy”. Ultrasound Obstetrics and Gynecology (2020).
  10. Munster VJ., et al. “A novel coronavirus emerging in China-key questions for impact assessment”. The New England Journal of Medicine 382 (2020): 692-694.
  11. Mali YS., et al. “Emerging novel coronavirus (2019-nCoV)-current scenario, evolutionary perspective based on genome analysis and recent developments”. Journal Veterinary Quarterly (2020): 40.
  12. Fan C., et al. “Perinatal Transmission of COVID-19 Associated SARS-CoV-2: Should We Worry?” Clinical Infectious Diseases (2020).


Citation: Goce Kalcev., et al. “Novel Coronavirus Disease (COVID-19): Pregnancy Issues”. Acta Scientific Women's Health 2.7 (2020): 12-13.


Acceptance rate35%
Acceptance to publication20-30 days

Indexed In

News and Events

  • Certification for Review
    Acta Scientific certifies the Editors/reviewers for their review done towards the assigned articles of the respective journals.
  • Submission Timeline for Upcoming Issue
    The last date for submission of articles for regular Issues is May 20, 2024.
  • Publication Certificate
    Authors will be issued a "Publication Certificate" as a mark of appreciation for publishing their work.
  • Best Article of the Issue
    The Editors will elect one Best Article after each issue release. The authors of this article will be provided with a certificate of "Best Article of the Issue"
  • Welcoming Article Submission
    Acta Scientific delightfully welcomes active researchers for submission of articles towards the upcoming issue of respective journals.

Contact US